TECHNOLOGY ACCESS PROGRAM
NEWS
PEOPLE
LEADERSHIP
PARTNERS
JOIN US
LEARN
OUR PRODUCTS
APPLICATIONS
PUBLICATIONS
BROCHURES
FLOWFECT® CONNECT
CONTACT
REQUEST QUOTE
SUPPORT
TECHNOLOGY ACCESS PROGRAM
NEWS
PEOPLE
LEADERSHIP
PARTNERS
JOIN US
LEARN
OUR PRODUCTS
APPLICATIONS
PUBLICATIONS
BROCHURES
FLOWFECT® CONNECT
CONTACT
REQUEST QUOTE
SUPPORT
Applications
The intersection of innovation and opportunity
September 17 - 20, 2024
A Non-viral Pathway to GMP Manufacture Engineered Cell Therapies – Maximizing Yields of Highest Quality Cells
July 16 - 21, 2023
Understanding DNA Delivery on the Flowfect Discover™ Platform
January 26, 2023
BioCentriq Results of Study Designed to Test Transfection of T-Cells Using Kytopen's Flowfect® Platform
October 11-14, 2022
Delivery of mRNA and CRISPR-Cas9 RNP to primary Natural Killer cells and T cells using Flowfect®, a new transfection technology
May 4-7, 2022
CRISPR-Cas9 RNP editing of primary T cells using the Flowfect® transfection technology platform
May 16-19, 2022
CRISPR-Cas9 RNP Editing of Primary T Cells Using the Flowfect® Transfection Technology Platform
May 12-15, 2020
Flowfect®: A scalable non-viral delivery process for T cell engineering
June 23-27, 2020
Flowfect® Transfection of iPSCs Maintains Cell Pluripotency
December 31, 1969
October 24 - 27, 2023
Optimization and characterization of donor-to-donor variability of primary natural killer cells transfected with RNP
Can't find what you're looking for?
Contact Us